山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
26期
11-13
,共3页
任恺%程亮%易蔚%赵璧君%王晓武%苏洁%易定华
任愷%程亮%易蔚%趙璧君%王曉武%囌潔%易定華
임개%정량%역위%조벽군%왕효무%소길%역정화
脂联素抵抗%心脏瓣膜疾病%脂联素%腺苷酸活化蛋白激酶
脂聯素牴抗%心髒瓣膜疾病%脂聯素%腺苷痠活化蛋白激酶
지련소저항%심장판막질병%지련소%선감산활화단백격매
adiponectin resistance%heart valve disease%adiponectin%AMP-activated protein kinase
目的:探讨心脏瓣膜病患者心肌组织脂联素抵抗及其相关机制。方法选择行体外循环下瓣膜置换手术的心脏瓣膜病患者36例为观察组,心脏移植捐献者及心脏外伤需手术患者22例为对照组。两组均手术中体外循环建立时剪除心肌组织,用RT-PCR法检测脂联素表达,Western Blot法检测脂联素下游通路重要分子腺苷酸活化蛋白激酶( AMPK)活性,HE染色观察心肌组织病理情况。结果与对照组相比,观察组心肌组织脂联素mRNA表达显著升高,AMPK活性显著降低,P均<0.05。心肌组织病理改变与相应心功能特点相符。结论心脏瓣膜病患者心肌组织脂联素水平显著升高,脂联素受体后AMPK磷酸化水平降低导致脂联素无法发挥正常的心肌保护效应,心脏瓣膜病患者的心肌组织出现脂联素抵抗。
目的:探討心髒瓣膜病患者心肌組織脂聯素牴抗及其相關機製。方法選擇行體外循環下瓣膜置換手術的心髒瓣膜病患者36例為觀察組,心髒移植捐獻者及心髒外傷需手術患者22例為對照組。兩組均手術中體外循環建立時剪除心肌組織,用RT-PCR法檢測脂聯素錶達,Western Blot法檢測脂聯素下遊通路重要分子腺苷痠活化蛋白激酶( AMPK)活性,HE染色觀察心肌組織病理情況。結果與對照組相比,觀察組心肌組織脂聯素mRNA錶達顯著升高,AMPK活性顯著降低,P均<0.05。心肌組織病理改變與相應心功能特點相符。結論心髒瓣膜病患者心肌組織脂聯素水平顯著升高,脂聯素受體後AMPK燐痠化水平降低導緻脂聯素無法髮揮正常的心肌保護效應,心髒瓣膜病患者的心肌組織齣現脂聯素牴抗。
목적:탐토심장판막병환자심기조직지련소저항급기상관궤제。방법선택행체외순배하판막치환수술적심장판막병환자36례위관찰조,심장이식연헌자급심장외상수수술환자22례위대조조。량조균수술중체외순배건립시전제심기조직,용RT-PCR법검측지련소표체,Western Blot법검측지련소하유통로중요분자선감산활화단백격매( AMPK)활성,HE염색관찰심기조직병리정황。결과여대조조상비,관찰조심기조직지련소mRNA표체현저승고,AMPK활성현저강저,P균<0.05。심기조직병리개변여상응심공능특점상부。결론심장판막병환자심기조직지련소수평현저승고,지련소수체후AMPK린산화수평강저도치지련소무법발휘정상적심기보호효응,심장판막병환자적심기조직출현지련소저항。
Objective To investigate the effect of adiponectin resistance on heart valve disease and the related resist -ance mechanism .Methods Thirty-six patients undergoing cardiopulmonary bypass ( CPB) heart valve replacement surger-y ( the treatment group ) and 22 cases of heart transplant donors who needed heart surgery ( the control group ) were select-ed.The myocardial tissues which were cut off in the cardiac operation under CPB were collected .The adiponectin expres-sion in the myocardial tissue samples was detected by RT-PCR.The adiponectin important molecular pathways downstream AMP-activated protein kinase ( AMPK) activity was detected by Western blotting .The cardiac pathology was detected by HE staining method.Results Compared with the control group , adiponectin mRNA was significantly higher , and the level of downstream pathways AMPK phosphorylation was significantly lower in the treatment group (all P<0.01).Histopathol-ogy results complied with the appropriate cardiac function of myocardial performance .Conclusion The adiponectin levels in the tissues of patients with heart valve disease are significantly increased , but adiponectin receptor AMP-activated protein kinase ( AMPK) phosphorylation levels are decreased , thus adiponectin can not play the protective effect , and myocardial tissues of patients show adiponectin resistance .